Glenza 80

Glenza 80 Specification

Salt Composition
Enzalutamide 80 mg

Brand Name
Glenza 80

Pacakaging (Quantity Per Box)
14 Capsules per box

Packaging Type
Blister pack in box

Indication
Metastatic castration-resistant prostate cancer (mCRPC)

Life Span
Refer to expiry date on packaging

Dosage Form
Capsule

Origin of Medicine
India

Drug Type
Allopathic

Ingredients
Enzalutamide

Physical Form
Capsule

Function
Anti-cancer (Prostate Cancer therapy)

Recommended For
Prostate Cancer Patients

Dosage
As prescribed by physician

Dosage Guidelines
Take as directed by an oncologist or physician

Suitable For
Adults (Male)

Quantity
1 strip of 14 capsules

Storage Instructions
Store below 30C; protect from moisture and light

Schedule
Schedule H (India)

Therapeutic Class
Oncology

Warning
To be sold by retail on the prescription of an oncologist only

Net Content
Each capsule contains Enzalutamide 80 mg

Dispensing Requirement
Prescription required

Colour of Capsule
Yellow/Orange

Route of Administration
Oral

Moisture Protection
Yes, blister packaging

Glenza 80 Trade Information

Minimum Order Quantity
10 Tablet

Supply Ability
Tablet

Delivery Time
12 To 24 Hours

About Glenza 80

Experience a brilliant, hot deal on Glenza 80-our best-seller for advanced prostate cancer therapy. This reduced-price antineoplastic agent delivers 80 mg of paragon-quality Enzalutamide per yellow capsule, formulated for oral use and exclusively intended for prescription-only treatment. Glenza 80 is manufactured by Glenmark Pharmaceuticals Ltd. and comes in a secure blister pack containing 14 capsules with a detailed product insert. Approved by top health authorities in India, Glenza 80 is a prime choice for men seeking effective management of metastatic castration-resistant prostate cancer. Take only as prescribed and under medical supervision.

Extra Features, Uses, and Application of Glenza 80

Glenza 80 stands out for its advanced formulation, providing 80 mg of Enzalutamide in each expertly designed yellow capsule. Used for the treatment of metastatic castration-resistant prostate cancer (mCRPC), this medication serves as a reliable anti-cancer therapy. Glenza 80 is specifically used as an oral solution, suited for adult male patients, and is packaged in a convenient 14-capsule box to ensure dosage precision and patient safety.

Glenza 80 Supply, Export Markets, and Purchase Process

Glenza 80 enjoys significant export demand in international markets while maintaining strong presence in India's domestic pharmaceutical sector. With a robust supply ability, Glenmark Pharmaceuticals efficiently handles both high-volume proposal amounts and smaller orders. Upon receipt of a valid purchase order, your medicine is promptly dispatched with all required documentation. Buyers can expect timely delivery and professional service throughout the process, maintaining the highest standards for quality assurance and regulatory compliance.

FAQ's of Glenza 80:

Q: How should Glenza 80 capsules be taken?

A: Glenza 80 capsules should be swallowed whole with water. Do not chew or crush the capsules. Take the medication exactly as directed by your physician or oncologist for the best therapeutic effect.

Q: What is Glenza 80 primarily used for?

A: Glenza 80 is primarily used for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in adult male patients. It functions as an anti-cancer agent to help control the progression of prostate cancer.

Q: When should I avoid taking Glenza 80?

A: You should not take Glenza 80 if you are allergic to Enzalutamide or any of its ingredients. Always inform your doctor about any medications you are currently taking to prevent adverse interactions.

Q: Where is Glenza 80 manufactured and marketed?

A: Glenza 80 is manufactured and marketed by Glenmark Pharmaceuticals Ltd. in India. The medication is approved by relevant health authorities in India for cancer therapy use.

Q: What are common side effects associated with Glenza 80?

A: Common side effects include fatigue, headache, hypertension, hot flashes, and musculoskeletal pain. Consult your physician if you experience unusual symptoms or if any side effects persist or worsen during treatment.